Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1996 Oct;49(5):M301–M307. doi: 10.1136/mp.49.5.m301

Amphotericin B induced abnormalities in human platelets

K B Pastakia 1, N E Brownson 1, D A Terle 1, B J Poindexter 1
PMCID: PMC408077  PMID: 16696093

Abstract

Aims—To investigate in vitro the effect of amphotericin B on platelets in order to understand poor platelet recovery in patients receiving platelet transfusions and amphotericin B simultaneously.

Methods—Washed platelets were isolated from platelet concentrates and exposed to amphotericin B (4 μg/ml) for one hour. Platelet function was assessed by aggregation response to thrombin (0-0.6 U/ml), serotonin release, response to hypotonic stress, and mean platelet volume. The expression of surface membrane glycoprotein (GP) Ib-IX complex, GPIIb-IIIa complex and CD62P (P-selectin) was examined by flow cytometry using fluorescence labelled monoclonal antibodies. Heterotypic cell adhesion was measured in amphotericin B treated platelets coincubated with isolated, autologous polymorphonuclear leucocytes (PMN) by flow cytometric analysis.

Results—Amphotericin B induced platelet dysfunction. The rate of aggregation by thrombin, serotonin uptake and thrombin induced release of serotonin, and the response of platelets to hypotonic stress were inhibited. There was up to a two-fold increase in the mean platelet volume. The expression of platelet surface GPIb-IX and GPIIb-IIIa was not affected. P-selectin, normally expressed only on the surface of activated platelets, was also expressed on unactivated platelets. Amphotericin B increased platelet adherence to PMN and the number of platelets bound per PMN.

Conclusions—In vitro, amphotericin B induces P-selectin expression on the surface of unactivated platelets and increases platelet adhesion to PMN, which is exacerbated by storage. Platelet dysfunction resulting from exposure to amphotericin B may contribute to poor platelet recovery in vivo when amphotericin B is administered concomitantly with platelet transfusion.

Keywords: amphotericin B

Keywords: platelets

Keywords: surface membrane glycoprotein

Keywords: flow cytometry

Full text

PDF
M301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asa D., Raycroft L., Ma L., Aeed P. A., Kaytes P. S., Elhammer A. P., Geng J. G. The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins. J Biol Chem. 1995 May 12;270(19):11662–11670. doi: 10.1074/jbc.270.19.11662. [DOI] [PubMed] [Google Scholar]
  2. Berman C. L., Yeo E. L., Wencel-Drake J. D., Furie B. C., Ginsberg M. H., Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest. 1986 Jul;78(1):130–137. doi: 10.1172/JCI112542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bishop J. F., McGrath K., Wolf M. M., Matthews J. P., De Luise T., Holdsworth R., Yuen K., Veale M., Whiteside M. G., Cooper I. A. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood. 1988 Feb;71(2):383–387. [PubMed] [Google Scholar]
  4. Blum S. F., Shohet S. B., Nathan D. G., Gardner F. H. The effect of amphotericin B on erythrocyte membrane cation permeability: its relation to in vivo erythrocyte survival. J Lab Clin Med. 1969 Jun;73(6):980–987. [PubMed] [Google Scholar]
  5. Dutcher J. P., Kendall J., Norris D., Schiffer C., Aisner J., Wiernik P. H. Granulocyte transfusion therapy and amphotericin B: adverse reactions? Am J Hematol. 1989 Jun;31(2):102–108. doi: 10.1002/ajh.2830310206. [DOI] [PubMed] [Google Scholar]
  6. Ezzone S. Can amphotericin-B and blood components be given simultaneously. ONS News. 1995 Sep;10(9):6–6. [PubMed] [Google Scholar]
  7. Fratantoni J. C., Poindexter B. J. Characterization of the platelet response to exogenous arachidonic acid. Thromb Res. 1981 Apr 1;22(1-2):157–166. doi: 10.1016/0049-3848(81)90317-0. [DOI] [PubMed] [Google Scholar]
  8. Fratantoni J. C., Poindexter B. J. Measuring platelet aggregation with microplate reader. A new technical approach to platelet aggregation studies. Am J Clin Pathol. 1990 Nov;94(5):613–617. doi: 10.1093/ajcp/94.5.613. [DOI] [PubMed] [Google Scholar]
  9. Gary-Bobo C. M. Polyene--sterol interaction and selective toxicity. Biochimie. 1989 Jan;71(1):37–47. doi: 10.1016/0300-9084(89)90129-6. [DOI] [PubMed] [Google Scholar]
  10. Hamburger S. A., McEver R. P. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 1990 Feb 1;75(3):550–554. [PubMed] [Google Scholar]
  11. Harvath L., Balke J. A., Christiansen N. P., Russell A. A., Skubitz K. M. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis. J Immunol. 1991 Feb 1;146(3):949–957. [PubMed] [Google Scholar]
  12. Keyes S. R., Rudnick G. Coupling of transmembrane proton gradients to platelet serotonin transport. J Biol Chem. 1982 Feb 10;257(3):1172–1176. [PubMed] [Google Scholar]
  13. Larsen E., Celi A., Gilbert G. E., Furie B. C., Erban J. K., Bonfanti R., Wagner D. D., Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989 Oct 20;59(2):305–312. doi: 10.1016/0092-8674(89)90292-4. [DOI] [PubMed] [Google Scholar]
  14. McGrath K., Bertram J. F., Houghton S., Boothman J., Manderson J. A., Minchinton R. Amphotericin B-induced injury in stored human platelets. Transfusion. 1992 Jan;32(1):46–50. doi: 10.1046/j.1537-2995.1992.32192116432.x. [DOI] [PubMed] [Google Scholar]
  15. Michelson A. D., Barnard M. R. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood. 1987 Nov;70(5):1673–1678. [PubMed] [Google Scholar]
  16. Norol F., Kuentz M., Cordonnier C., Beaujean F., Haioun C., Vernant J. P., Duédari N. Influence of clinical status on the efficiency of stored platelet transfusion. Br J Haematol. 1994 Jan;86(1):125–129. doi: 10.1111/j.1365-2141.1994.tb03262.x. [DOI] [PubMed] [Google Scholar]
  17. Pastakia K. B., Terle D., Prodouz K. N. Penicillin-induced dysfunction of platelet membrane glycoproteins. J Lab Clin Med. 1993 Apr;121(4):546–554. [PubMed] [Google Scholar]
  18. Rinder H. M., Snyder E. L., Bonan J. L., Napychank P. A., Malkus H., Smith B. R. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion. 1993 Jan;33(1):25–29. doi: 10.1046/j.1537-2995.1993.33193142305.x. [DOI] [PubMed] [Google Scholar]
  19. Sloand E. M., Kumar P., Yu M., Klein H. G. Effect of amphotericin B and fluconazole on platelet membrane glycoproteins. Transfusion. 1994 May;34(5):415–420. doi: 10.1046/j.1537-2995.1994.34594249054.x. [DOI] [PubMed] [Google Scholar]
  20. Terrell C. L., Hughes C. E. Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc. 1992 Jan;67(1):69–91. doi: 10.1016/s0025-6196(12)60281-x. [DOI] [PubMed] [Google Scholar]
  21. Triulzi D. J., Kickler T. S., Braine H. G. Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion. 1992 Jul-Aug;32(6):529–533. doi: 10.1046/j.1537-2995.1992.32692367196.x. [DOI] [PubMed] [Google Scholar]
  22. Wright D. G., Robichaud K. J., Pizzo P. A., Deisseroth A. B. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med. 1981 May 14;304(20):1185–1189. doi: 10.1056/NEJM198105143042001. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES